Clinical Trials
32
Active:2
Completed:18
Trial Phases
4 Phases
Phase 1:8
Phase 2:4
Phase 3:2
+1 more phases
Drug Approvals
14
PHILIPPINES:10
NPRA:2
NMPA:1
+1 more agencies
Drug Approvals
Clinical Trials
Distribution across different clinical trial phases (23 trials with phase data)• Click on a phase to view related trials
Not Applicable
9 (39.1%)Phase 1
8 (34.8%)Phase 2
4 (17.4%)Phase 3
2 (8.7%)No trials found
News
Alveolus Bio Secures Strategic Investment from Shilpa Medicare to Advance Respiratory Therapeutics Platform
Alveolus Bio announced a strategic financing round led by Shilpa Medicare Limited, positioning the company for Phase 2 clinical trials and first-in-human studies of its respiratory therapeutics platform.
Shilpa Pharma Lifesciences Unit-1 Passes Brazilian ANVISA GMP Inspection with No Critical Findings
Shilpa Pharma Lifesciences Limited, Unit-1 successfully completed a GMP inspection by Brazilian regulatory authority ANVISA from June 30-July 4, 2025, with no critical or major observations.
Orion and Shilpa Medicare Partner to Bring Recombinant Human Albumin to European Market
Orion Corporation has secured exclusive rights to distribute, market, and sell Shilpa Medicare's Recombinant Human Albumin across Europe, strengthening their position in value-add hospital generics.